Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.

Journal: Multiple sclerosis and related disorders

Publication date: 

Journal: Multiple sclerosis and related disorders

Publication Year: 

Authors & Co-authors:  Zeineddine Maya M Al-Hajje Amal A Salameh Pascale P Massouh Joelle J Saab Georges G Al-Roughani Raed R Ahmed Samar Farouk SF Al-Mahdawi Akram A Shalaby Nevin N Inshasi Jihad J

Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication date: 

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 

Authors & Co-authors:  Zeineddine Maya M Al-Roughani Raed R Farouk Ahmed Samar S Khoury Samia S El-Ayoubi Nabil N Al-Mahdawi Akram A Al-Khabouri Jaber J Al-Asmi Abdullah A Chentouf Amina A Inshasi Jihad J